Storia della carriera di Phillips N. Dee
Precedenti posizioni note di Phillips N. Dee
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
RegenoCELL Therapeutics, Inc.
 RegenoCELL Therapeutics, Inc. BiotechnologyHealth Technology RegenoCELL Therapeutics, Inc. develops a stem-cell therapy business for the treatment of congestive heart failure and peripheral artery disease. It utilizes adult stem cells, derived from the patient's own blood, which eliminates the ethical and safety concerns associated with embryonic and umbilical cord blood stem cells. The stem cell therapy is either delivered through a catheter or injected directly into the myocardium. The company was founded by Scott Massey on February 1, 2002 and is headquartered in Natick, MA. | Direttore/Membro del Consiglio | 01/02/2002 | 16/07/2008 |
Formazione di Phillips N. Dee
| The University of North Carolina at Charlotte | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
Posizioni
| Director/Board Member | 1 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 2 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
RegenoCELL Therapeutics, Inc.
RegenoCELL Therapeutics, Inc. BiotechnologyHealth Technology RegenoCELL Therapeutics, Inc. develops a stem-cell therapy business for the treatment of congestive heart failure and peripheral artery disease. It utilizes adult stem cells, derived from the patient's own blood, which eliminates the ethical and safety concerns associated with embryonic and umbilical cord blood stem cells. The stem cell therapy is either delivered through a catheter or injected directly into the myocardium. The company was founded by Scott Massey on February 1, 2002 and is headquartered in Natick, MA. | Health Technology |
- Borsa valori
- Insiders
- Phillips N. Dee
- Esperienza
